DOW JONES23,719.37+285.80 1.22%
S&P 5002,789.82+39.84 1.45%
NASDAQ8,153.58+62.67 0.77%

Cantor Fitzgerald Reiterates Overweight on OptiNose, Lowers Price Target to $21

Cantor Fitzgerald analyst Brandon Folkes reiterates OptiNose (NASDAQ:OPTN) with a Overweight and lowers the price target from $27 to $21.

Benzinga · 03/05/2020 17:58

Cantor Fitzgerald analyst Brandon Folkes reiterates OptiNose (NASDAQ:OPTN) with a Overweight and lowers the price target from $27 to $21.